Allergen immunotherapy for IgE-mediated food allergy

There is a measure in everything to a proper proportion of therapy

Giovanni Battista Pajno, Riccardo Castagnoli, Antonella Muraro, Montserrat Alvaro-Lozano, Cezmi A Akdis, Műbeccel Akdis, Stefania Arasi

Research output: Contribution to journalArticle

Abstract

IgE-mediated food allergy (FA) is a potentially life-threatening condition with a negative impact on quality of life and an increasing prevalence in westernized countries in the recent two decades. A strict avoidance of the triggering food(s) represents the current standard approach. However, an elimination diet may be difficult and frustrating, in particular for common foods, (eg, milk, egg, and peanut). Food allergy immunotherapy (FA-AIT) may provide an active treatment that enables to increase the amount of food that the patient can intake without reaction during treatment (ie, desensitization), and reduces the risk of potential life-threatening allergic reaction in the event of accidental ingestion. However, several gaps need still to be filled. A memorable Latin orator stated: "Est modus in rebus" (Horace, Sermones I, 1, 106-07). This sentence remembers that there is a measure in everything to a proper proportion of therapy. The common sense of measure should find application in each stage of treatment. A personalized approaching should consider the specific willing and features of each patient. Efforts are devoted to improve the efficacy, the safety but also the quality of life of patients suffering from FA. In the near future, it will be important to clarify immunologic pathways of FA-AIT, and to identify reliable biomarkers in order to recognize the most suitable candidates to FA-AIT and algorithms for treatments tailored on well-characterized subpopulations of patients.

Original languageEnglish
JournalPediatric Allergy and Immunology
DOIs
Publication statusE-pub ahead of print - Feb 15 2019

Fingerprint

Immunologic Desensitization
Food Hypersensitivity
Immunoglobulin E
Food
Therapeutics
Quality of Life
Nimodipine
Immunotherapy
Ovum
Hypersensitivity
Milk
Eating
Biomarkers
Diet
Safety

Cite this

Allergen immunotherapy for IgE-mediated food allergy : There is a measure in everything to a proper proportion of therapy. / Pajno, Giovanni Battista; Castagnoli, Riccardo; Muraro, Antonella; Alvaro-Lozano, Montserrat; Akdis, Cezmi A; Akdis, Műbeccel; Arasi, Stefania.

In: Pediatric Allergy and Immunology, 15.02.2019.

Research output: Contribution to journalArticle

Pajno, Giovanni Battista ; Castagnoli, Riccardo ; Muraro, Antonella ; Alvaro-Lozano, Montserrat ; Akdis, Cezmi A ; Akdis, Műbeccel ; Arasi, Stefania. / Allergen immunotherapy for IgE-mediated food allergy : There is a measure in everything to a proper proportion of therapy. In: Pediatric Allergy and Immunology. 2019.
@article{d50e64c7c60946a6b1130dbf35b8fa3f,
title = "Allergen immunotherapy for IgE-mediated food allergy: There is a measure in everything to a proper proportion of therapy",
abstract = "IgE-mediated food allergy (FA) is a potentially life-threatening condition with a negative impact on quality of life and an increasing prevalence in westernized countries in the recent two decades. A strict avoidance of the triggering food(s) represents the current standard approach. However, an elimination diet may be difficult and frustrating, in particular for common foods, (eg, milk, egg, and peanut). Food allergy immunotherapy (FA-AIT) may provide an active treatment that enables to increase the amount of food that the patient can intake without reaction during treatment (ie, desensitization), and reduces the risk of potential life-threatening allergic reaction in the event of accidental ingestion. However, several gaps need still to be filled. A memorable Latin orator stated: {"}Est modus in rebus{"} (Horace, Sermones I, 1, 106-07). This sentence remembers that there is a measure in everything to a proper proportion of therapy. The common sense of measure should find application in each stage of treatment. A personalized approaching should consider the specific willing and features of each patient. Efforts are devoted to improve the efficacy, the safety but also the quality of life of patients suffering from FA. In the near future, it will be important to clarify immunologic pathways of FA-AIT, and to identify reliable biomarkers in order to recognize the most suitable candidates to FA-AIT and algorithms for treatments tailored on well-characterized subpopulations of patients.",
author = "Pajno, {Giovanni Battista} and Riccardo Castagnoli and Antonella Muraro and Montserrat Alvaro-Lozano and Akdis, {Cezmi A} and Műbeccel Akdis and Stefania Arasi",
note = "{\circledC} 2019 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.",
year = "2019",
month = "2",
day = "15",
doi = "10.1111/pai.13042",
language = "English",
journal = "Pediatric Allergy and Immunology",
issn = "0905-6157",
publisher = "Blackwell Munksgaard",

}

TY - JOUR

T1 - Allergen immunotherapy for IgE-mediated food allergy

T2 - There is a measure in everything to a proper proportion of therapy

AU - Pajno, Giovanni Battista

AU - Castagnoli, Riccardo

AU - Muraro, Antonella

AU - Alvaro-Lozano, Montserrat

AU - Akdis, Cezmi A

AU - Akdis, Műbeccel

AU - Arasi, Stefania

N1 - © 2019 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

PY - 2019/2/15

Y1 - 2019/2/15

N2 - IgE-mediated food allergy (FA) is a potentially life-threatening condition with a negative impact on quality of life and an increasing prevalence in westernized countries in the recent two decades. A strict avoidance of the triggering food(s) represents the current standard approach. However, an elimination diet may be difficult and frustrating, in particular for common foods, (eg, milk, egg, and peanut). Food allergy immunotherapy (FA-AIT) may provide an active treatment that enables to increase the amount of food that the patient can intake without reaction during treatment (ie, desensitization), and reduces the risk of potential life-threatening allergic reaction in the event of accidental ingestion. However, several gaps need still to be filled. A memorable Latin orator stated: "Est modus in rebus" (Horace, Sermones I, 1, 106-07). This sentence remembers that there is a measure in everything to a proper proportion of therapy. The common sense of measure should find application in each stage of treatment. A personalized approaching should consider the specific willing and features of each patient. Efforts are devoted to improve the efficacy, the safety but also the quality of life of patients suffering from FA. In the near future, it will be important to clarify immunologic pathways of FA-AIT, and to identify reliable biomarkers in order to recognize the most suitable candidates to FA-AIT and algorithms for treatments tailored on well-characterized subpopulations of patients.

AB - IgE-mediated food allergy (FA) is a potentially life-threatening condition with a negative impact on quality of life and an increasing prevalence in westernized countries in the recent two decades. A strict avoidance of the triggering food(s) represents the current standard approach. However, an elimination diet may be difficult and frustrating, in particular for common foods, (eg, milk, egg, and peanut). Food allergy immunotherapy (FA-AIT) may provide an active treatment that enables to increase the amount of food that the patient can intake without reaction during treatment (ie, desensitization), and reduces the risk of potential life-threatening allergic reaction in the event of accidental ingestion. However, several gaps need still to be filled. A memorable Latin orator stated: "Est modus in rebus" (Horace, Sermones I, 1, 106-07). This sentence remembers that there is a measure in everything to a proper proportion of therapy. The common sense of measure should find application in each stage of treatment. A personalized approaching should consider the specific willing and features of each patient. Efforts are devoted to improve the efficacy, the safety but also the quality of life of patients suffering from FA. In the near future, it will be important to clarify immunologic pathways of FA-AIT, and to identify reliable biomarkers in order to recognize the most suitable candidates to FA-AIT and algorithms for treatments tailored on well-characterized subpopulations of patients.

U2 - 10.1111/pai.13042

DO - 10.1111/pai.13042

M3 - Article

JO - Pediatric Allergy and Immunology

JF - Pediatric Allergy and Immunology

SN - 0905-6157

ER -